Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $8.14, but opened at $8.79. Aspen Pharmacare shares last traded at $8.79, with a volume of 200 shares.
Aspen Pharmacare Price Performance
The company has a quick ratio of 2.66, a current ratio of 3.64 and a debt-to-equity ratio of 0.36. The firm’s 50 day simple moving average is $8.14 and its 200-day simple moving average is $7.21.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Read More
- Five stocks we like better than Aspen Pharmacare
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
- Palomar’s High-Risk Insurance Strategy Is Paying Off Big
- Marvell’s Pullback May Be the Setup Bulls Were Waiting For
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
